Compare MIST & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | FICO |
|---|---|---|
| Founded | 2003 | 1956 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 34.7B |
| IPO Year | 2019 | 1995 |
| Metric | MIST | FICO |
|---|---|---|
| Price | $1.76 | $1,096.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $8.50 | ★ $1,961.08 |
| AVG Volume (30 Days) | ★ 1.2M | 255.4K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.80 | 29.78 |
| EPS | N/A | ★ 6.61 |
| Revenue | N/A | ★ $1,032,475,000.00 |
| Revenue This Year | N/A | $27.68 |
| Revenue Next Year | N/A | $17.15 |
| P/E Ratio | ★ N/A | $175.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $1,146.69 |
| 52 Week High | $3.06 | $2,217.60 |
| Indicator | MIST | FICO |
|---|---|---|
| Relative Strength Index (RSI) | 50.38 | 25.76 |
| Support Level | $1.62 | N/A |
| Resistance Level | $1.79 | $1,562.48 |
| Average True Range (ATR) | 0.08 | 71.66 |
| MACD | 0.02 | -19.33 |
| Stochastic Oscillator | 86.54 | 3.86 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.